Evidence map›Paper›PMID 39990307›Full record

ArticlebioRxiv : the preprint server for biology2025

A functional map of phosphoprotein phosphatase regulation identifies an evolutionary conserved reductase for the catalytic metal ions.

Bob Meeusen, Sara M Ambjørn, Jiri Veis, Rachel C Riley, Gianmatteo Vit, Brooke L Brauer, Mads H Møller, Elora C Greiner, Camilla B Chan, Melanie B Weisser and 6 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Bob MeeusenNovo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, DK.
Sara M AmbjørnNovo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, DK.
Jiri VeisMax Perutz Labs, Vienna Biocenter Campus (VBC), Dr.-Bohr-Gasse 9 / Vienna Biocenter 5, 1030, Vienna, Austria. Medical University of Vienna, Max Perutz Labs, Dr.-Bohr-Gasse 9 / Vienna Biocenter 5, 1030, Vienna, Austria.
Rachel C RileyDepartment of Biochemistry and Cell Biology, Dartmouth Geisel School of Medicine, Hanover, NH, USA.
Gianmatteo VitNovo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, DK.
Brooke L BrauerDepartment of Biochemistry and Cell Biology, Dartmouth Geisel School of Medicine, Hanover, NH, USA.
Mads H MøllerNovo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, DK.
Elora C GreinerDepartment of Biochemistry and Cell Biology, Dartmouth Geisel School of Medicine, Hanover, NH, USA.
Camilla B ChanNovo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, DK.
Melanie B WeisserNovo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, DK.
Dimitriya H GarvanskaNovo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, DK.
Hao ZhuUniversity of Kansas Medical Center, Kansas City, KS, USA.
Norman E DaveyInstitute of Cancer Research, London, UK.
Arminja N KettenbachDepartment of Biochemistry and Cell Biology, Dartmouth Geisel School of Medicine, Hanover, NH, USA.
Egon OgrisMax Perutz Labs, Vienna Biocenter Campus (VBC), Dr.-Bohr-Gasse 9 / Vienna Biocenter 5, 1030, Vienna, Austria. Medical University of Vienna, Max Perutz Labs, Dr.-Bohr-Gasse 9 / Vienna Biocenter 5, 1030, Vienna, Austria.
Jakob NilssonNovo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, DK.

Funding

University of Kansas Alzheimer's Disease Research Center (KU ADRC)P30AG072973 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Mohammad Haeri · 2021 to 2026
$25.3M
Phosphorylation Signaling by Phosphoprotein PhosphatasesR35GM119455 · NIGMS · DARTMOUTH COLLEGE · PI Arminja Nadine Kettenbach · 2016 to 2026
$5.1M
NIA NIH HHS P30 AG072973NIGMS NIH HHS R35 GM119455
6 · The paper itself

Abstract

Serine/Threonine phosphoprotein phosphatases (PPPs, PP1-PP7) are conserved metalloenzymes and central to intracellular signaling in eukaryotes, but the details of their regulation is poorly understood. To address this, we performed genome-wide CRISPR knockout and focused base editor screens in PPP perturbed conditions to establish a high-resolution functional map of PPP regulation that pinpoints novel regulatory mechanisms. Through this, we identify the orphan reductase CYB5R4 as an evolutionarily conserved activator of PP4 and PP6, but not the closely related PP2A. Heme binding is essential for CYB5R4 function and mechanistically involves the reduction of the metal ions in the active site. Importantly, CYB5R4-mediated activation of PP4 is critical for cell viability when cells are treated with DNA damage-inducing agents known to cause oxidative stress. The discovery of a dedicated PPP reductase points to shared regulatory principles with protein tyrosine phosphatases, where specific enzymes dictate activity by regulating the active site redox state. In sum, our work provides a resource for understanding PPP function and the regulation of intracellular signaling.

Identifiers

PMID39990307
PMCPMC11844454

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.